Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice Guidelines
| Authors: | Maas, M.; Beets-Tan, R.; Gaubert, J. Y.; Gomez Munoz, F.; Habert, P.; Klompenhouwer, L. G.; Vilares Morgado, P.; Schaefer, N.; Cornelis, F. H.; Solomon, S. B.; van der Reijd, D.; Bilbao, J. I. |
| Title: | Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice |
| Abstract: | Interventional radiology plays an important and increasing role in cancer treatment. Follow-up is important to be able to assess treatment success and detect locoregional and distant recurrence and recommendations for follow-up are needed. At ECIO 2018, a joint ECIO-ESOI session was organized to establish follow-up recommendations for oncologic intervention in liver, renal, and lung cancer. Treatments included thermal ablation, TACE, and TARE. In total five topics were evaluated: ablation in colorectal liver metastases (CRLM), TARE in CRLM, TACE and TARE in HCC, ablation in renal cancer, and ablation in lung cancer. Evaluated modalities were FDG-PET-CT, CT, MRI, and (contrast-enhanced) ultrasound. Prior to the session, five experts were selected and performed a systematic review and presented statements, which were voted on in a telephone conference prior to the meeting by all panelists. These statements were presented and discussed at the ECIO-ESOI session at ECIO 2018. This paper presents the recommendations that followed from these initiatives. Based on expert opinions and the available evidence, follow-up schedules were proposed for liver cancer, renal cancer, and lung cancer. FDG-PET-CT, CT, and MRI are the recommended modalities, but one should beware of false-positive signs of residual tumor or recurrence due to inflammation early after the intervention. There is a need for prospective preferably multicenter studies to validate new techniques and new response criteria. This paper presents recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies. © 2020, The Author(s). |
| Keywords: | cancer chemotherapy; treatment response; overall survival; cancer recurrence; cancer risk; cancer staging; nuclear magnetic resonance imaging; follow up; diagnostic accuracy; clinical practice; progression free survival; computer assisted tomography; tumor volume; lung cancer; oncology; cancer therapy; cancer mortality; intervention study; liver; systematic review; contrast enhancement; tumor recurrence; echography; fluorodeoxyglucose f 18; interventional radiology; cryoablation; diffusion weighted imaging; meta analysis; predictive value; recommendations; single photon emission computed tomography; fine needle aspiration biopsy; contrast-enhanced ultrasound; radioembolization; human; article; positron emission tomography-computed tomography; microwave thermotherapy |
| Journal Title: | Insights into Imaging |
| Volume: | 11 |
| ISSN: | 1869-4101 |
| Publisher: | SpringerOpen |
| Date Published: | 2020-01-01 |
| Start Page: | 83 |
| Language: | English |
| DOI: | 10.1186/s13244-020-00884-5 |
| PROVIDER: | scopus |
| PMCID: | PMC7366866 |
| PUBMED: | 32676924 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 3 August 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work